Insulin dose or glycemic control for the critically ill?

被引：2

作者：

Bertolini, G ^{[1
]}

Latronico, N

Brazzi, L

Radrizzani, D

机构：

[1] GiViTI Coordinating Ctr, Lab Epidemiol Clin, Ist Ric Farmacol Mario Negri, Ranica, Bergamo, Italy

[2] Univ Brescia, Ist Anestesia & Rianimaz, Spedali Civili, Brescia, Italy

[3] Osped Maggiore, Policlin IRCCS, Ist Anestesia & Rianimaz, Milan, Italy

[4] Osped Civile, Serv Anestesia & Rianimaz 1, Legnano, Milano, Italy

来源：

关键词：

D O I：

10.1097/01.CCM.0000089930.85158.17

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：2565 / 2566

页数：2

共 5 条

[1] Groeneveld ABJ, 2002, CRIT CARE, V6, P102
[2] Hosmer D. W., 1989, APPL LOGISTIC REGRES, DOI DOI 10.1097/00019514-200604000-00003
[3] ALTERATIONS IN CARBOHYDRATE-METABOLISM DURING STRESS - A REVIEW OF THE LITERATURE
MIZOCK, BA
[J]. AMERICAN JOURNAL OF MEDICINE, 1995, 98 (01) : 75 - 84
[4] Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control
Van den Berghe, G
Wouters, PJ
Bouillon, R
Weekers, F
Verwaest, C
Schetz, M
Vlasselaers, D
Ferdinande, P
Lamers, P
[J]. CRITICAL CARE MEDICINE, 2003, 31 (02) : 359 - 366
[5] Intensive insulin therapy in critically ill patients.
Van den Berghe, G
Wouters, P
Weekers, F
Verwaest, C
Bruyninckx, F
Schetz, M
Vlasselaers, D
Ferdinande, P
Lauwers, P
Bouillon, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (19) : 1359 - 1367